Advertisement

Systematrophien

  • W. Paulus

Zusammenfassung

Systematrophien sind hereditäre oder sporadische, progressive, degenerative Prozesse, die schwerpunktmäßig ein neuronales System betreffen (wie z.B. bei der amyotrophen Lateralsklerose das erste und zweite motorische Neuron, bei der Parkinson-Krankheit das nigrostriatale Neuron). Das retrograde oder anterograde (transneuronale) Übergreifen auf das funktionell gekoppelte folgende bzw. vorausgehende Neuron ist häufig, die Beteiligung weiterer neuronaler Systeme die Regel (Tabelle 13.1).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Albin R L, Young A B, Penney J B (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366–375PubMedCrossRefGoogle Scholar
  2. Braak H, Braak E (1992) Allocortical involvement in Huntington’s disease. Neuropathol Appl Neurobiol 18: 539–547PubMedCrossRefGoogle Scholar
  3. Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial „Clinical limits of amyotrophic lateral sclerosis“ workshop contributors. J Neurol Sci 124 (Suppl): 96–107PubMedCrossRefGoogle Scholar
  4. Bugiani O, Murreil J R, Giaccone G etal. (1999) Frontotemporal dementia and corticobasal degeneration in a family with a P301 S mutation in tau. J Neuropathol Exp Neurol 58: 667–677PubMedCrossRefGoogle Scholar
  5. Calne D B (ed) (1993) Neurodegenerative diseases. Saunders, LondonGoogle Scholar
  6. Cardoso F, Vargas A P, Oliveira L D, Guerra A A, Amaral S V (1999) Persistent Sydenham’s chorea. Mov Disord 14: 805–807PubMedCrossRefGoogle Scholar
  7. Cervós-Navarro J, Urich H (1995) Metabolic and degenerative diseases of the central nervous system. Pathology, biochemistry, and genetics. Academic Press, San DiegoGoogle Scholar
  8. Cordato N J, Halliday G M, Harding A J, Hely M A, Morris J G (2000) Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 47: 718–728PubMedCrossRefGoogle Scholar
  9. Dale G E, Probst A, Luthert P etal. (1992) Relationship between Lewy bodies and pale bodies in Parkinson’s disease. Acta Neuropathol 83: 525–529PubMedCrossRefGoogle Scholar
  10. Dickson D W (1999 a) Symposium: tau and synuclein in neuropathology. Brain Pathol 9: 657–739Google Scholar
  11. Dickson D W (1999 b) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246 Suppl 2: 6–15Google Scholar
  12. Dickson D W, Wertkin A, Kress Y, Ksiezak-Reding H, Yen S H (1990) Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab Invest 63: 87–99PubMedGoogle Scholar
  13. Dickson D W, Liu W, Hardy J etal. (1999) Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol 155: 1241–1251PubMedCrossRefGoogle Scholar
  14. Fischbeck K H, Lieberman A, Bailey C K, Abel A, Merry D E (1999) Androgen receptor mutation in Kennedy’s disease. Philos Trans R Soc Lond B Biol Sci 354: 1075–1078PubMedCrossRefGoogle Scholar
  15. Forno L S, Langston J W, DeLanney L E, Irwin I (1988) An electron microscopic study of MPTP-induced inclusion bodies in an old monkey. Brain Res 448: 150–157PubMedCrossRefGoogle Scholar
  16. Geddes J F, Hughes A J, Lees A J, Daniel S E (1993) Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. Brain 116: 281–302PubMedCrossRefGoogle Scholar
  17. Gendron N H, MacKenzie A E (1999) Spinal muscular atrophy: molecular pathophysiology. Curr Opin Neurol 12: 137–142PubMedCrossRefGoogle Scholar
  18. Genis D, Davalos A, Molins A, Ferrer I (1997) Wolfram syndrome: a neuropathological study. Acta Neuropathol 93: 426–429PubMedCrossRefGoogle Scholar
  19. Gibb W R G (1989) Neuropathology in movement disorders. J Neurol Neurosurg Psychiatry Suppl 54: 55–67CrossRefGoogle Scholar
  20. Gibb W R G, Lees A (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson’s disease. Neuropathol Appl Neurobiol 15: 27–44PubMedCrossRefGoogle Scholar
  21. Gutekunst C A, Li S H, Yi H etal. (1999) Nuclear and neuropil aggregates in Huntington’s disease: relationship to neuropathology. J Neurosci 19: 2522–2534PubMedGoogle Scholar
  22. Hardie R J, Pullon H W H, Harding A E etal. (1991) Neuro-acanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 114: 13–49PubMedGoogle Scholar
  23. Hayashi Y, Kakita A, Yamada M etal. (1998) Hereditary dentatorubral-pallidoluysian atrophy: detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain. Acta Neuropathol 96: 547–552PubMedCrossRefGoogle Scholar
  24. Hedreen J C, Peyser C E, Folstein S E, Ross C A (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington’s disease. Neurosci Lett 133: 257–261PubMedCrossRefGoogle Scholar
  25. Higgins J J, Adler R L, Loveless J M (1999) Mutational analysis of the tau gene in progressive supranuclear palsy. Neurology 53: 1421–1424PubMedGoogle Scholar
  26. Hsu L J, Sagara Y, Arroyo A etal. (2000) α-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157: 401–410Google Scholar
  27. Ince P G, Lowe J, Shaw P J (1998) Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 24: 104–117PubMedCrossRefGoogle Scholar
  28. Ishizawa K, Lin W L, Tiseo P, Honer W G, Davies P, Dickson D W (2000) A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy. J Neuropathol Exp Neurol 59: 513–524PubMedGoogle Scholar
  29. Jackson M, Lennox G, Lowe J (1996) Motor neurone disease-inclusion dementia. Neurodegeneration 5: 339–350PubMedCrossRefGoogle Scholar
  30. Jellinger K (1986) Pallidal, pallidonigral and pallidoluysioni- gral degenerations including association with thalamic and dentate degenerations. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of Clinical Neurology, vol 5. Elsevier, Amsterdam, pp 445–463Google Scholar
  31. Jellinger K (1998) Neuropathology of movement disorders. Neurosurg Clin North Am 9: 237–262Google Scholar
  32. Jellinger K (1999) Post mortem studies in Parkinson’s disease: is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 56: 1–29PubMedGoogle Scholar
  33. Joseph, AB, Young, RR (Hrsg) (1999) Movement disorders in neurology and neuropsychiatry, 2nd edn. Blackwell, OxfordGoogle Scholar
  34. Kanazawa I (1999) Molecular pathology of dentatorubral-pallidoluysian atrophy. Philos Trans R Soc Lond B Biol Sci 354: 1069–1074PubMedCrossRefGoogle Scholar
  35. Kato S, Hirano A (1990) Ubiquitin and phosphorylated neurofilament epitopes in ballooned neurons of the extraocular muscle nuclei in a case of Werdnig-Hoffmann disease. Acta Neuropathol 80: 334–337PubMedCrossRefGoogle Scholar
  36. Kitada T, Asakawa S, Matsumine H etal. (2000) Progress in the clinical and molecular genetics of familial parkinsonism. Neurogenet 2: 207–218CrossRefGoogle Scholar
  37. Koeppen A H (1998) The hereditary ataxias. J Neuropathol Exp Neurol 57: 531–543PubMedCrossRefGoogle Scholar
  38. Komori T (1999) Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick’s disease. Brain Pathol 9: 663–679PubMedCrossRefGoogle Scholar
  39. Kushner PD, Stephenson DT, Wright S (1991) Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol 50: 263–277PubMedCrossRefGoogle Scholar
  40. Leigh P N, Whitwell H, Garofalo O etal. (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 114: 775–788PubMedCrossRefGoogle Scholar
  41. Li A, Swift M (2000) Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet 92: 170–177PubMedCrossRefGoogle Scholar
  42. Li H, Li S H, Johnston H, Shelbourne P F, Li X J (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat Genet 25: 385–389PubMedCrossRefGoogle Scholar
  43. Litvan I, Hauw J J, Bartko J J etal. (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55: 97–105PubMedCrossRefGoogle Scholar
  44. Lodi R, Cooper J M, Bradley J L etal. (1999) Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci USA 96: 11492–11495PubMedCrossRefGoogle Scholar
  45. Lowe J, Mayer R J, Landon M (1993) Ubiquitin in neurodegenerative diseases. Brain Pathol 3: 55–65PubMedCrossRefGoogle Scholar
  46. Ludolph A C, Meyer T, Riepe M W (2000) The role of excitotoxicity in ALS. What is the evidence? J Neurol 247 (Suppl 1): I 7–16Google Scholar
  47. Mann D M A, Oliver R, Snowden J S (1993) The topographic distribution of brain atrophy in Huntington’s disease and progressive supranuclear palsy. Acta Neuropathol 85: 553–559PubMedGoogle Scholar
  48. Matsumoto S, Kusaka H, Murakami N etal. (1992) Basophilic inclusions in sporadic juvenile amyotrophic lateral sclerosis: an immunocytochemical and ultrastructural study. Acta Neuropathol 83: 579–583PubMedCrossRefGoogle Scholar
  49. McDermott C J, White K, Bushby K, Shaw P J (2000) Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry 69: 150–160PubMedCrossRefGoogle Scholar
  50. Miyoshi Y, Yamada T, Tanimura M etal. (2001) A novel autosomal dominant spinocerebellar ataxia (SCA16) linked to chromosome 8q22.1–24.1. Neurology 57: 96–100PubMedGoogle Scholar
  51. Monaco S, Nardelli E, Moretto G, Cavallaro T, Rizzuto N (1988) Cytoskeletal pathology in ataxia-telangiectasia. Clin Neuropathol 7: 44–46PubMedGoogle Scholar
  52. Murayama S, Bouldin T W, Suzuki K (1992) Immunocytochemical and ultrastructural studies of upper motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol 83: 518–524PubMedCrossRefGoogle Scholar
  53. Oppenheimer D R (1979) Brain lesions in Friedreich’s ataxia. Can J Neurol Sci 6: 173–176PubMedGoogle Scholar
  54. Oppenheimer D R (1988) Neuropathology of autonomic failure. In: Bannister R (ed) Autonomic failure, 2nd edn. Oxford University Press, pp 451–463Google Scholar
  55. Orrell R W (2000) Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations. Neuromuscul Disord 10: 63–68PubMedCrossRefGoogle Scholar
  56. Oyanagi K, Wada M (1999) Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: an update. J Neurol 246 (Suppl 2): 19–27CrossRefGoogle Scholar
  57. Papp M I, Lantos P L (1994) The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 117: 235–243PubMedCrossRefGoogle Scholar
  58. Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50: 743–755PubMedCrossRefGoogle Scholar
  59. Pringle C E, Hudson A J, Munoz D G etal. (1992) Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 115: 495–520PubMedCrossRefGoogle Scholar
  60. Rabin B A, Griffin J W, Crain B J, Scavina M, Chance P F, Cornblath D R (1999) Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 122: 1539–1550PubMedCrossRefGoogle Scholar
  61. Rajput A H, Uitti R J, Sudhakar S, Rozdilsky B (1989) Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei. Ann Neurol 25: 602–606PubMedCrossRefGoogle Scholar
  62. Robberecht W (2000) Oxidative stress in amyotrophic lateral sclerosis. J Neurol 247 (Suppl 1): 1–6CrossRefGoogle Scholar
  63. Sandmann-Keil D, Braak H, Okochi M, Haass C, Braak E (1999) Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson’s disease are detectable by an advanced silver-staining technique. Acta Neuropathol 98: 461–464PubMedCrossRefGoogle Scholar
  64. Shankar S K, Gourie-Devi M, Shankar L, Yasha T C, Santosh V, Das S (2000) Pathology of Madras type of motor neuron disease (MMND). A histological and immunohistochem- ical study. Acta Neuropathol 99: 428–434PubMedCrossRefGoogle Scholar
  65. Shimada A, Lange D J, Hays A P (1999) Amyotrophic lateral sclerosis in an adult following acute paralytic poliomyelitis in early childhood. Acta Neuropathol 97: 317–321PubMedCrossRefGoogle Scholar
  66. Shishikura K, Hara M, Sasaki Y, Misugi K (1983) A neuropathologic study of Werdnig-Hoffmann disease with special reference to the thalamus and posterior roots. Acta Neuropathol 60: 99–106PubMedCrossRefGoogle Scholar
  67. Stanford P M, Halliday G M, Brooks W S etal. (2000) Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain 123: 880–893PubMedCrossRefGoogle Scholar
  68. Stevanin G, Durr A, Brice A (2000) Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J Hum Genet 8: 4–18PubMedCrossRefGoogle Scholar
  69. Suzuki Y, Murakami N, Goto Y etal. (1997) Apoptotic nuclear degeneration in Marinesco-Sjogren syndrome. Acta Neuropathol 94: 410–415PubMedCrossRefGoogle Scholar
  70. The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72: 971–983Google Scholar
  71. Tokuda T, Ikeda S, Yanagisawa N, Ihara Y, Glenner G G (1991) Re-examination of ex-boxers’ brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein. Acta Neuropathol 82: 280–285PubMedCrossRefGoogle Scholar
  72. van Duijn C M, Dekker M C J, Bonifati V etal. (2001) PARK7, a novel locus for autosomal recessive early-onset Parkinsonism, on chromosome lp36. Am J Hum Genet 69: 629–634PubMedCrossRefGoogle Scholar
  73. Vazza G, Zortea M, Boaretto F, Micaglio G F, Sartori V, Mostacciuolo M L (2000) A new locus for autosomal-recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG 14, maps to chromosome 3q27-q28. Am J Hum Genet 67: 504–509PubMedCrossRefGoogle Scholar
  74. Vonsattel J P, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57: 369–384PubMedCrossRefGoogle Scholar
  75. Vonsattel J P, Myers R H, Stevens T J etal. (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44: 559–577PubMedCrossRefGoogle Scholar
  76. Wada M, Uchihara T, Nakamura A, Oyanagi K (1999) Bunina bodies in amyotrophic lateral sclerosis on Guam: a histochemical, immunohistochemical and ultrastructural investigation. Acta Neuropathol 98: 150–156PubMedCrossRefGoogle Scholar
  77. Wenning G K, Ben-Shlomo Y, Magalhaes M, Daniel S E, Quinn N P (1995) Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 58: 160–166PubMedCrossRefGoogle Scholar
  78. White K D, Ince P G, Lusher M etal. (2000) Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology 55: 89–94PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • W. Paulus

There are no affiliations available

Personalised recommendations